Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Subjects

NCT03999853 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03999853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03999853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Subjects
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
July 28, 2022
Completion date
December 1, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type1diabetes